Theme Templates,  —

Recent Posts

• Approval Advances Psilocybin Treatment Plans in Canada
• Oral NNI-351 Awarded Orphan Drug Status by FDA
• NNI-351 Earns Rare Pediatric Disease Designation From FDA
• FMR1 Gene Renamed to Increase Accuracy and Remove Stigmatizing Language
• Study Supports Development of Preventive Treatments for FXTAS
• Organizations Rally to Help Ukrainian Rare Disease Patients
• Low Cholesterol in Cells’ Lipid Rafts May Add to Behavioral Differences
• Europe Awaits Proposed New Framework for Sharing Health Data
• Telehealth Added to Latest Digital-friendly NORD State Report Card
• Lovastatin, Minocycline Combined Helps Fragile X Behavior, Caregivers Report